CDH2 and cancer: Following the same protocol as the immunofluorescence of cancer cells, RAW-Blue macrophages were treated with either TGFβ-1 (4.0 × 10−3 μg/mL), IL-6 (4.1 × 10−5 μg/mL), or HGF (5.97 × 10−4 μg/mL) and stained with E-cadherin, N-cadherin, and vimentin (Figure 14).